WashU researchers have discovered why cells communicate mechanically through the extracellular matrix, but only within a ...
Our CXU™ platform represents a next-generation liquid extracellular matrix, which provides a complex and bioactive scaffold ...
Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat ...
Conexeu Sciences Inc. ("Conexeu" or the "Company"), a pre-commercial biotechnology company redefining regenerative medicine through next-generation ...
Cellular changes that appear during melanoma and lead to treatment resistance can be reversed with drugs—potentially opening ...
Cellular changes that appear during melanoma and lead to treatment resistance can be reversed with drugs - potentially ...
Caltech researchers have reintroduced a classic technique to image the formation and growth of individual cells that make up biofilms, sticky masses of millions of cells that are often responsible for ...
Retinal vein occlusion (RVO) is one of the leading causes of vision loss worldwide, often triggered by chronic diseases such as hypertension and diabetes. Similar to a blocked water pipe causing ...
Elutia's stock narrative saw minimal movement in its fair value estimate, which remains steady at $4.00 per share after the latest business update. Analysts attribute this stability to the recent sale ...
Researchers have developed a hydrogel that lasts longer than current treatments for vocal fold disorders and could reduce the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback